nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ABCB1—peripheral nervous system neoplasm	0.453	1	CbGaD
Indacaterol—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.103	0.248	CbGbCtD
Indacaterol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0523	0.126	CbGbCtD
Indacaterol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0523	0.126	CbGbCtD
Indacaterol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0362	0.0871	CbGbCtD
Indacaterol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0313	0.0753	CbGbCtD
Indacaterol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0291	0.07	CbGbCtD
Indacaterol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0223	0.0537	CbGbCtD
Indacaterol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0208	0.05	CbGbCtD
Indacaterol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0204	0.0492	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0139	0.0335	CbGbCtD
Indacaterol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0134	0.0321	CbGbCtD
Indacaterol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0122	0.0295	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00835	0.0201	CbGbCtD
Indacaterol—Myalgia—Topotecan—peripheral nervous system neoplasm	0.000526	0.004	CcSEcCtD
Indacaterol—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000525	0.004	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000522	0.00397	CcSEcCtD
Indacaterol—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.000521	0.00397	CcSEcCtD
Indacaterol—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.000521	0.00397	CcSEcCtD
Indacaterol—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.000521	0.00397	CcSEcCtD
Indacaterol—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000521	0.00397	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000518	0.00394	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000518	0.00394	CcSEcCtD
Indacaterol—Chest pain—Melphalan—peripheral nervous system neoplasm	0.000515	0.00392	CcSEcCtD
Indacaterol—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000515	0.00392	CcSEcCtD
Indacaterol—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.000511	0.00389	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000511	0.00389	CcSEcCtD
Indacaterol—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00051	0.00388	CcSEcCtD
Indacaterol—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00051	0.00388	CcSEcCtD
Indacaterol—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.000505	0.00384	CcSEcCtD
Indacaterol—Infection—Topotecan—peripheral nervous system neoplasm	0.000501	0.00381	CcSEcCtD
Indacaterol—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000497	0.00378	CcSEcCtD
Indacaterol—Infection—Tretinoin—peripheral nervous system neoplasm	0.000497	0.00378	CcSEcCtD
Indacaterol—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000494	0.00376	CcSEcCtD
Indacaterol—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00049	0.00373	CcSEcCtD
Indacaterol—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00049	0.00373	CcSEcCtD
Indacaterol—Infection—Melphalan—peripheral nervous system neoplasm	0.00049	0.00373	CcSEcCtD
Indacaterol—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000489	0.00373	CcSEcCtD
Indacaterol—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000488	0.00371	CcSEcCtD
Indacaterol—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000488	0.00371	CcSEcCtD
Indacaterol—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000486	0.0037	CcSEcCtD
Indacaterol—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000486	0.0037	CcSEcCtD
Indacaterol—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000482	0.00367	CcSEcCtD
Indacaterol—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000479	0.00365	CcSEcCtD
Indacaterol—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.000477	0.00363	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00358	CcSEcCtD
Indacaterol—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.000466	0.00355	CcSEcCtD
Indacaterol—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.00353	CcSEcCtD
Indacaterol—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.000464	0.00353	CcSEcCtD
Indacaterol—Infestation—Etoposide—peripheral nervous system neoplasm	0.000464	0.00353	CcSEcCtD
Indacaterol—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000463	0.00353	CcSEcCtD
Indacaterol—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000463	0.00352	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000459	0.0035	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000455	0.00347	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000455	0.00347	CcSEcCtD
Indacaterol—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000452	0.00345	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00045	0.00342	CcSEcCtD
Indacaterol—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000449	0.00342	CcSEcCtD
Indacaterol—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000449	0.00342	CcSEcCtD
Indacaterol—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000449	0.00342	CcSEcCtD
Indacaterol—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000446	0.0034	CcSEcCtD
Indacaterol—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000446	0.00339	CcSEcCtD
Indacaterol—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000446	0.00339	CcSEcCtD
Indacaterol—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000443	0.00337	CcSEcCtD
Indacaterol—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00044	0.00335	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.00331	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000435	0.00331	CcSEcCtD
Indacaterol—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000435	0.00331	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000432	0.00329	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000432	0.00329	CcSEcCtD
Indacaterol—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00327	CcSEcCtD
Indacaterol—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000426	0.00325	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000426	0.00324	CcSEcCtD
Indacaterol—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000422	0.00321	CcSEcCtD
Indacaterol—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000413	0.00315	CcSEcCtD
Indacaterol—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00312	CcSEcCtD
Indacaterol—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.00312	CcSEcCtD
Indacaterol—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000409	0.00312	CcSEcCtD
Indacaterol—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000406	0.00309	CcSEcCtD
Indacaterol—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00308	CcSEcCtD
Indacaterol—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000402	0.00306	CcSEcCtD
Indacaterol—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000395	0.00301	CcSEcCtD
Indacaterol—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.00301	CcSEcCtD
Indacaterol—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.00301	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.00299	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000388	0.00295	CcSEcCtD
Indacaterol—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000386	0.00294	CcSEcCtD
Indacaterol—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000386	0.00294	CcSEcCtD
Indacaterol—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000381	0.0029	CcSEcCtD
Indacaterol—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00038	0.0029	CcSEcCtD
Indacaterol—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.00287	CcSEcCtD
Indacaterol—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000376	0.00286	CcSEcCtD
Indacaterol—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000375	0.00286	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000372	0.00283	CcSEcCtD
Indacaterol—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.00283	CcSEcCtD
Indacaterol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000371	0.00283	CcSEcCtD
Indacaterol—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000371	0.00282	CcSEcCtD
Indacaterol—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00282	CcSEcCtD
Indacaterol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000368	0.0028	CcSEcCtD
Indacaterol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000368	0.0028	CcSEcCtD
Indacaterol—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000368	0.0028	CcSEcCtD
Indacaterol—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000366	0.00278	CcSEcCtD
Indacaterol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000364	0.00277	CcSEcCtD
Indacaterol—Infection—Vincristine—peripheral nervous system neoplasm	0.000363	0.00276	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.00273	CcSEcCtD
Indacaterol—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000358	0.00273	CcSEcCtD
Indacaterol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000357	0.00271	CcSEcCtD
Indacaterol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000354	0.00269	CcSEcCtD
Indacaterol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000354	0.00269	CcSEcCtD
Indacaterol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000349	0.00266	CcSEcCtD
Indacaterol—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000348	0.00265	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000345	0.00263	CcSEcCtD
Indacaterol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.00259	CcSEcCtD
Indacaterol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.00257	CcSEcCtD
Indacaterol—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000337	0.00256	CcSEcCtD
Indacaterol—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000335	0.00255	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000334	0.00255	CcSEcCtD
Indacaterol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000333	0.00254	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000333	0.00253	CcSEcCtD
Indacaterol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000331	0.00252	CcSEcCtD
Indacaterol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000331	0.00252	CcSEcCtD
Indacaterol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000328	0.0025	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.00249	CcSEcCtD
Indacaterol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000326	0.00248	CcSEcCtD
Indacaterol—Infection—Cisplatin—peripheral nervous system neoplasm	0.000321	0.00244	CcSEcCtD
Indacaterol—Rash—Topotecan—peripheral nervous system neoplasm	0.000318	0.00242	CcSEcCtD
Indacaterol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000317	0.00242	CcSEcCtD
Indacaterol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000317	0.00241	CcSEcCtD
Indacaterol—Cough—Etoposide—peripheral nervous system neoplasm	0.000316	0.00241	CcSEcCtD
Indacaterol—Headache—Topotecan—peripheral nervous system neoplasm	0.000316	0.0024	CcSEcCtD
Indacaterol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000315	0.0024	CcSEcCtD
Indacaterol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000315	0.0024	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000315	0.0024	CcSEcCtD
Indacaterol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000315	0.0024	CcSEcCtD
Indacaterol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000315	0.0024	CcSEcCtD
Indacaterol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000315	0.0024	CcSEcCtD
Indacaterol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000314	0.00239	CcSEcCtD
Indacaterol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000313	0.00238	CcSEcCtD
Indacaterol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000313	0.00238	CcSEcCtD
Indacaterol—Rash—Melphalan—peripheral nervous system neoplasm	0.000311	0.00237	CcSEcCtD
Indacaterol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000311	0.00237	CcSEcCtD
Indacaterol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000308	0.00235	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000307	0.00234	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000306	0.00233	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000302	0.0023	CcSEcCtD
Indacaterol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000301	0.00229	CcSEcCtD
Indacaterol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000299	0.00228	CcSEcCtD
Indacaterol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000297	0.00226	CcSEcCtD
Indacaterol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000297	0.00226	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000294	0.00224	CcSEcCtD
Indacaterol—Infection—Etoposide—peripheral nervous system neoplasm	0.000294	0.00224	CcSEcCtD
Indacaterol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000293	0.00223	CcSEcCtD
Indacaterol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000291	0.00222	CcSEcCtD
Indacaterol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00029	0.00221	CcSEcCtD
Indacaterol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000289	0.0022	CcSEcCtD
Indacaterol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000288	0.00219	CcSEcCtD
Indacaterol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000287	0.00219	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00216	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000284	0.00216	CcSEcCtD
Indacaterol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.00213	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.00212	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000279	0.00212	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00206	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00205	CcSEcCtD
Indacaterol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000269	0.00205	CcSEcCtD
Indacaterol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.00204	CcSEcCtD
Indacaterol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000266	0.00202	CcSEcCtD
Indacaterol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000264	0.00201	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000263	0.002	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.002	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00199	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00198	CcSEcCtD
Indacaterol—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00026	0.00198	CcSEcCtD
Indacaterol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000258	0.00196	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000255	0.00194	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00191	CcSEcCtD
Indacaterol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.00191	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00186	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00185	CcSEcCtD
Indacaterol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000243	0.00185	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00184	CcSEcCtD
Indacaterol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000241	0.00184	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00183	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00183	CcSEcCtD
Indacaterol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00182	CcSEcCtD
Indacaterol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00182	CcSEcCtD
Indacaterol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000238	0.00181	CcSEcCtD
Indacaterol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00181	CcSEcCtD
Indacaterol—Rash—Vincristine—peripheral nervous system neoplasm	0.00023	0.00175	CcSEcCtD
Indacaterol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00023	0.00175	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00023	0.00175	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00175	CcSEcCtD
Indacaterol—Headache—Vincristine—peripheral nervous system neoplasm	0.000229	0.00174	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00172	CcSEcCtD
Indacaterol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00171	CcSEcCtD
Indacaterol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000218	0.00166	CcSEcCtD
Indacaterol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000217	0.00165	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00165	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00162	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00162	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000211	0.0016	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00021	0.0016	CcSEcCtD
Indacaterol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000209	0.00159	CcSEcCtD
Indacaterol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000204	0.00155	CcSEcCtD
Indacaterol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000203	0.00155	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00155	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00153	CcSEcCtD
Indacaterol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000196	0.00149	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00149	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00148	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00148	CcSEcCtD
Indacaterol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000192	0.00146	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00143	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00143	CcSEcCtD
Indacaterol—Rash—Etoposide—peripheral nervous system neoplasm	0.000186	0.00142	CcSEcCtD
Indacaterol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000186	0.00142	CcSEcCtD
Indacaterol—Headache—Etoposide—peripheral nervous system neoplasm	0.000185	0.00141	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00139	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00138	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00137	CcSEcCtD
Indacaterol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000177	0.00135	CcSEcCtD
Indacaterol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000176	0.00134	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00132	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00132	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00132	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00131	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000169	0.00129	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00129	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00126	CcSEcCtD
Indacaterol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00125	CcSEcCtD
Indacaterol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00125	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00124	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00123	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00123	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00122	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00122	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00121	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00119	CcSEcCtD
Indacaterol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00116	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00115	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00115	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00114	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00113	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00113	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00113	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00109	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00106	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00105	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00104	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00101	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00093	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000893	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00086	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000835	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000826	CcSEcCtD
Indacaterol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000796	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000795	CcSEcCtD
Indacaterol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000791	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000772	CcSEcCtD
Indacaterol—Nausea—Epirubicin—peripheral nervous system neoplasm	9.85e-05	0.00075	CcSEcCtD
Indacaterol—Rash—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000736	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000736	CcSEcCtD
Indacaterol—Headache—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000732	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000694	CcSEcCtD
